Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 5:55 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–96 of 1,750 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: Northwestern University Clear all

Conditions: PreDiabetes, Heart Rate Variability (HRV), Stress and Anxiety, Stress Biomarkers
Interventions: Nature-based Walking, Built-environment/Commercial Walking; Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 25 Years to 64 Years
Enrollment: 216 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 3
States / cities: Lake Forest, Illinois • Winfield, Illinois • Minneapolis, Minnesota

Conditions: Achalasia
Interventions: Per-Oral Endoscopic Esophagomyotomy; Procedure
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Major Salivary Gland Carcinoma, Minor Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage IV Major Salivary Gland Carcinoma, Stage IVA Major Salivary Gland Carcinoma, Stage IVB Major Salivary Gland Carcinoma, Stage IVC Major Salivary Gland Carcinoma
Interventions: Ipilimumab, Laboratory Biomarker Analysis, Nivolumab; Biological · Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Actinic Keratoses
Interventions: ALA (5-aminolevulinic acid), Blue light therapy; Drug · Device
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: ESRD
Interventions: Hispanic Kidney Transplant Program (HKTP); Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 11,836 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 4
States / cities: Phoenix, Arizona • Denver, Colorado • Dallas, Texas + 1 more

Conditions: Sarcoidosis
Interventions: Autologous hematopoietic stem cell transplantation, Allogeneic stem cell transplantation; Biological
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2015
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: End Stage Renal Disease
Interventions: Expanded Tregs; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Lymphoma
Interventions: tretinoin; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1991 – 2002
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Suicide, Attempted
Interventions: Attempted Suicide Short Intervention Program, Zero Suicide Usual Care; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 443 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 3
States / cities: Rochester, New York • Syracuse, New York

Conditions: Lymphoma
Interventions: Pegylated interferon α-2b, Psoralens with ultraviolet light A, Narrowband-ultraviolet light B; Biological · Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 120 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Colorectal Cancer, Constipation, Impaction, and Bowel Obstruction, Extrahepatic Bile Duct Cancer, Gastric Cancer, Gastrointestinal Carcinoid Tumor, Gastrointestinal Stromal Tumor, Pancreatic Cancer, Quality of Life, Small Intestine Cancer
Interventions: bowel obstruction management, quality-of-life assessment; Procedure
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2003
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Rheumatoid Arthritis
Interventions: Not listed
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 18 Years and older
Enrollment: 119 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Fibroids, Uterine, Fluid Deficit, Hysteroscopy / Methods
Interventions: Misoprostol Tabets, Placebo; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Infant Development, Cerebral Palsy, Motor Disorders, Neurological Disorder
Interventions: Observational; Other
Lead sponsor: Ann & Robert H Lurie Children's Hospital of Chicago; Other
Eligibility: 10 Weeks to 20 Weeks
Enrollment: 350 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Scarring Alopecia, Central Centrifugal Cicatricial Alopecia, Central Centrifugal Scarring Alopecia
Interventions: 53-Item Survey; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Carcinoma, Recurrent Islet Cell Carcinoma
Interventions: temozolomide, pazopanib hydrochloride; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2021
U.S. locations: 5
States / cities: Chicago, Illinois • Ann Arbor, Michigan • Philadelphia, Pennsylvania + 2 more

Conditions: Brain Concussion
Interventions: Ibuprofen, Acetaminophen; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 21 Years to 60 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Low Back Pain
Interventions: Milnacipran, Placebo; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Sickle Cell Disease
Interventions: Pain self-management, Education; Behavioral
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 12 Years to 18 Years
Enrollment: 137 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 3
States / cities: Hartford, Connecticut • Atlanta, Georgia • Seattle, Washington

Conditions: Dizziness
Interventions: Embedded Emergency Department Physical Therapy, Usual Care; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Chicago, Illinois • Salt Lake City, Utah

Conditions: Achalasia
Interventions: POEM-F, Conventional POEM; Procedure
Lead sponsor: Chinese University of Hong Kong; Other
Eligibility: 18 Years to 65 Years
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Prostate Cancer
Interventions: Ipilimumab; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Male only
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2027
U.S. locations: 3
States / cities: Evanston, Illinois • New York, New York • Portland, Oregon

Conditions: Fibroid Uterus, Endometriosis, Uterus Myoma, Uterine Fibroid, Uterine Adenomyosis, Endometrial Cyst, Uterine Cyst
Interventions: ICG; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Infectious Disease
Interventions: Not listed
Lead sponsor: Midwestern University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Downers Grove, Illinois

Search by objective public record fields.

Effects of Walking in Greenspace and the Built Environment in Adults With Prediabetes: A Randomized Crossover Trial

Per-Oral Endoscopic Esophagomyotomy (POEM)

Nivolumab and Ipilimumab in Treating Patients With Metastatic/Recurrent ACC of All Sites and Non-ACC Salivary Gland Cancer

Photodynamic Therapy Incubation Times for Actinic Keratosis

A Culturally Targeted Transplant Program

Hematopoietic Stem Cell Support in Patients With Refractory Sarcoidosis

Trial of Adoptive Immunotherapy With TRACT to Prevent Rejection in Living Donor Kidney Transplant Recipients

Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome

Study About Treatment After a Suicide Attempt

Study of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy In CTCL

Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction

Consortium of Early Arthritis Cohorts USA

Effect of Misoprostol on Fluid Deficit Volume in Hysteroscopic Myomectomy

Families Filming Infants Learning Movement

Barriers to Care and QOL for CCCA Patients

Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery

Ibuprofen Versus Acetaminophen for Treatment of Mild Traumatic Brain Injury

Effect of Milnacipran in Chronic Neuropathic Low Back Pain

iCanCope With Sickle Cell Pain

A Multi-Site Feasibility Trial of Embedded Emergency Department Physical Therapy for Dizziness

POEM-F for Achalasia International Study

Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer

ICG to Assess Ovarian Perfusion

Antibiotic Outbreak, Risk Factors for Never Event, Prediction of Inappropriate Use